Company OncoVista Innovative Therapies, Inc.
Equities
OVIT
US68232J1051
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | +9,900.00% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,558,530 | 23,558,530 ( 100.00 %) | 0 | 100.00 % |
Company contact information
OncoVista Innovative Therapies, Inc.
14785 Omicron Drive Suite 104
78245, San Antonio
+
Sector
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 2.36K | |
+42.42% | 54.04B | |
+43.57% | 41.96B | |
-1.42% | 41.92B | |
-7.59% | 28.35B | |
+11.35% | 26.35B | |
-22.10% | 19B | |
+7.43% | 13B | |
+28.35% | 12.28B | |
+25.52% | 12.19B |
- Stock Market
- Equities
- OVIT Stock
- Company OncoVista Innovative Therapies, Inc.